1. Appropriate Antipsychotic Use in Nursing Home Populations: A Wakeup Call to CMS.
- Author
-
Brandt N, Zarowitz B, Little MO, Galik E, and Desai A
- Subjects
- United States, Humans, Centers for Medicare and Medicaid Services, U.S., Nursing Homes, Skilled Nursing Facilities, Antipsychotic Agents therapeutic use
- Abstract
Competing Interests: Disclosure N.B. received a research grant from the National Institute of Aging, is an advisor to the Institute for Healthcare Improvement, an author/supplier to the American Geriatrics Society Beers Criteria, is on the participant data safety board of Pantheon and AHRQ, and has a leadership role in AGS Program Planning Committee Member. B.Z. received a research grant from the National Institute of Aging; is a consultant for Merck, Eli Lilly, and Akebia; is a speaker for the American Society of Healthsystem Pharmacists/American College of Clinical Pharmacy; is in the policy committee of the American Society of Consultant Pharmacists; is vice-chairperson, Workgroup 2, Pharmacy Health Information Technology; and a board member of the Foundation for American Medical Directors Association. M.L. is the president of AMDA–The Society for Post-Acute and Long-Term Care Medicine. E.G. received a research grant from the National Institute of Health; receives royalties from the Medbridge educational program; is a consultant for Otsuka; is the president-elect of the Beacon Institute; secretary of the Gerontological Advanced Practice Nurses Association Foundation; and editor in chief of Caring for the Ages. A.D. declares no conflicts of interest.
- Published
- 2023
- Full Text
- View/download PDF